As of close of business last night, Innoviva Inc.’s stock clocked out at $11.46, up 0.26% from its previous closing price of $11.43. In other words, the price has increased by $+0.03 from its previous closing price. On the day, 886837 shares were traded. INVA stock price reached its highest trading level at $11.57 during the session, while it also had its lowest trading level at $11.25.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Ratios:
To gain a deeper understanding of INVA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.96 whereas as Long-Term Debt/Eq ratio is at 0.79.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on July 20, 2022, initiated with a Neutral rating and assigned the stock a target price of $16.
On November 20, 2017, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 10 when Raifeld Pavel bought 3,000 shares for $10.87 per share. The transaction valued at 32,603 led to the insider holds 9,799 shares of the business.
Innoviva, Inc. bought 7,598,814 shares of INVA for $16,717,391 on Jul 11. The 10% Owner now owns 29,270,476 shares after completing the transaction at $2.20 per share. On Jul 08, another insider, Innoviva, Inc., who serves as the 10% Owner of the company, bought 11,671,662 shares for $2.20 each. As a result, the insider paid 25,677,656 and bolstered with 21,671,662 shares of the company.
Valuation Measures:
As of this moment, Innoviva’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.91, and their Forward P/E ratio for the next fiscal year is 9.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 1.41.
Stock Price History:
Over the past 52 weeks, INVA has reached a high of $20.71, while it has fallen to a 52-week low of $10.64. The 50-Day Moving Average of the stock is 12.35, while the 200-Day Moving Average is calculated to be 13.33.
Shares Statistics:
It appears that INVA traded 692.96K shares on average per day over the past three months and 971.51k shares per day over the past ten days. A total of 69.66M shares are outstanding, with a floating share count of 67.44M. Shares short for INVA as of Jan 30, 2023 were 8.95M with a Short Ratio of 8.38M, compared to 9.85M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 12.83% and a Short% of Float of 14.83%.
Dividends & Splits
The current Payout Ratio is 0.00% for INVA, which recently paid a dividend on Sep 29, 2015 with an ex-dividend date of Sep 07, 2015. Stock splits for the company last occurred on Jun 02, 2014 when the company split stock in a 1241:1000 ratio.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.22 for the current quarter, with a high estimate of $0.41 and a low estimate of $0.04, while EPS last year was $0.14. The consensus estimate for the next quarter is $0.38, with high estimates of $0.38 and low estimates of $0.38.
Analysts are recommending an EPS of between $4.09 and $4.09 for the fiscal current year, implying an average EPS of $4.09. EPS for the following year is $1.27, with 2 analysts recommending between $1.51 and $1.04.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $58.85M. It ranges from a high estimate of $66.4M to a low estimate of $51.3M. As of the current estimate, Innoviva Inc.’s year-ago sales were $107.68M, an estimated decrease of -45.30% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $62.4M, a decrease of -30.70% over than the figure of -$45.30% in the same quarter last year. There is a high estimate of $64.89M for the next quarter, whereas the lowest estimate is $59.9M.
A total of 3 analysts have provided revenue estimates for INVA’s current fiscal year. The highest revenue estimate was $363.84M, while the lowest revenue estimate was $316.84M, resulting in an average revenue estimate of $337.53M. In the same quarter a year ago, actual revenue was $391.87M, down -13.90% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $284.25M in the next fiscal year. The high estimate is $306.88M and the low estimate is $269.17M. The average revenue growth estimate for next year is down -15.80% from the average revenue estimate for this year.
